Andrea Ellis

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Will Solis, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrea Ellis:

Company Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. Director Common Stock 18,589 $910,861 $49.00 05 Aug 2025 Direct
BridgeBio Pharma, Inc. Director Stock Option (right to buy) 34,334 05 Aug 2025 Direct

Insider Reports Filed by Andrea Ellis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BBIO BridgeBio Pharma, Inc. 05 Aug 2025 3 -$553,636 4 Director 07 Aug 2025, 16:50
BBIO BridgeBio Pharma, Inc. 20 Jun 2025 2 $0 4 Director 24 Jun 2025, 19:12
BBIO BridgeBio Pharma, Inc. 14 Apr 2025 3 -$265,500 4 Director 16 Apr 2025, 17:39
BBIO BridgeBio Pharma, Inc. 01 Apr 2025 3 -$768,000 4 Director 03 Apr 2025, 17:11
BBIO BridgeBio Pharma, Inc. 21 Jun 2024 1 $0 4 Director 25 Jun 2024, 17:39
BBIO BridgeBio Pharma, Inc. 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:18
BBIO BridgeBio Pharma, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:28
BBIO BridgeBio Pharma, Inc. 15 Mar 2022 1 +$100,680 4 Director 17 Mar 2022, 16:05
BBIO BridgeBio Pharma, Inc. 17 Aug 2021 1 $0 4 Director 26 Aug 2021, 17:14
BBIO BridgeBio Pharma, Inc. 17 Aug 2021 0 $0 3 Director 26 Aug 2021, 16:35